Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Results
Phase 3
This trial looked at nilotinib for people with newly diagnosed chronic myeloid leukaemia (CML) with the Philadelphia chromosome.
This trial was also for people with CML that had a high level of a protein called BCR-ABL and whose leukaemia was in the chronic phase.
Recruitment start: 1 September 2010
Recruitment end: 15 July 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Marin
Novartis
Last reviewed: 1 June 2017
CRUK internal database number: 7274
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
